Wearable Devices Ltd. Secures Israel Innovation Authority Grant for Neural Rehabilitation Pilot Study

Wearable Devices Ltd. (NASDAQ: WLDS) has received approval from the Israel Innovation Authority for a $750,000 budget to support a clinical pilot with Soroka University Medical Center. The study will evaluate the Mudra Link neural wristband as a rehabilitation tool for patients with impaired grip-force control following motor-cortex injuries. This initiative extends the platform's patented surface EMG technology into quantitative neuro-muscular monitoring, aiming to improve accessibility, tracking, and outcomes in force-control therapy.

The company specializes in AI-powered touchless sensing wearables, with its consumer products including the Mudra Band and Mudra Link defining the neural input category for wrist-worn devices and brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems. The clinical pilot represents a significant expansion of the technology's applications beyond consumer electronics into the healthcare sector, specifically targeting rehabilitation needs.

Wearable Devices operates through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations. The company provides enterprise partners with advanced input solutions for immersive and interactive environments, from augmented reality/virtual reality/XR to smart environments. The latest news and updates relating to WLDS are available in the company's newsroom at https://ibn.fm/WLDS. This grant-funded research could potentially establish new standards for neural input technology in therapeutic applications, addressing a significant medical need while demonstrating the versatility of the company's core technology platform.

The Israel Innovation Authority's support indicates recognition of the technology's potential impact on rehabilitation medicine. By focusing on patients with motor-cortex injuries, the pilot addresses a population with specific rehabilitation challenges related to grip-force control. The quantitative neuro-muscular monitoring capabilities being developed could provide clinicians with more precise tools for tracking patient progress and adjusting therapeutic interventions. This represents a convergence of wearable technology, artificial intelligence, and clinical medicine that could transform rehabilitation approaches for neurological conditions affecting motor function.